News & Analysis on Clinical Trial Services & Contract Research And Development
Abingworth Management, a UK venture capital group, has raised a $350 million investment vehicle in a move that lends further weight to suggestions that the funding crisis hitting the biotechnology sector may be nearing its end.
MWG Biotech's laboratory automation platform THEONYX can now handle DNA microarray sample preparation for Afffymetrix' GeneChip products.
US antisense specialist Genta has agreed to acquire Salus Therapeutics, a specialist in small interfering RNA, for up to $30 million in cash and stock. The terms of the agreement call for Genta to issue $13 million in stock at closing.
A fluorescence imaging technology developed by Siemens promises to improve the in vivo imaging of molecular processes in drug discovery and disease research